31,109 resources
By Version
By Authority
By Realm
Start Prev Rows 3600 - 3800 Next
Package | Version | Identity | Name/Title | Status | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.16 | NHSNInfectionFirstReportedSource(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.18 | NHSNLOS/MENDischargeDisposition(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.20 | NHSNPopulationSummaryReportTypeCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.21 | NHSNPopulationSummaryReportTypeCode(LOINC) | active | 2020-08 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.22 | NHSNSameDayOutcomeMeasure(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.24 | NHSNSignificantPathogenCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.26 | NHSNSpinalFusionApproachCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.28 | NHSNVascularAccessTypeCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.30 | NHSNVascularSpecimenCollectionSite(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.38 | Blood Glucose Laboratory and Point of Care Tests | active | 2023-09 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO | active | 2025-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.63 | Bacterial and Fungal Blood Culture Tests | active | 2022-07 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.7 | NHSNRoleOfPerformerCode(CDCNHSN) | active | 2020-08 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route | active | 2022-07 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route | active | 2022-07 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.79 | Fidaxomicin, Vancomycin, and Metronidazole | active | 2022-07 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) | active | 2020-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.85 | Baloxavir | active | 2023-05 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.86 | Peramivir | active | 2023-05 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.87 | Zanamivir | active | 2023-05 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration | active | 2023-10 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.9 | NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy) | active | 2020-08 | us | hl7 | nucc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.90 | NHSN LTC AU Antimicrobial Agents | active | 2024-05 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition | active | 2024-01 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.94 | NHSNNeurogenicBladder | active | 2025-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.95 | NHSNSpinalCordInjury | active | 2025-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.147 | SCIP Major Surgical Procedure | active | 2019-06 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3483 | Financial Insecurity Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3484 | Food Insecurity Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3485 | Health Literacy Screening Assessments Questions | active | 2024-12 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3486 | Homelessness Screening Assessments Questions | active | 2023-08 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3487 | Housing Instability Screening Assessments Questions | active | 2023-08 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3488 | Less Than High School Education Screening Assessments Questions | active | 2023-07 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3519 | Health Insurance Coverage Status Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.3520 | Inadequate Housing Screening Assessments And Questions | active | 2023-07 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.393 | Hypoglycemics Severe Hypoglycemia | active | 2024-01 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.394 | Hypoglycemics Treatment Medications | active | 2025-02 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4448 | Lidocaine | active | 2024-05 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.491 | Medium Dose ICS Formoterol Preparations | active | 2021-09 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.495 | ICS LABA LAMA Preparations | active | 2021-09 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions | active | 2024-12 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.15 | General Surgery | active | 2020-04 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.17 | Coagulation Disorder Conditions | active | 2020-04 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.19 | Anticoagulant Medications | active | 2025-02 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.20 | Anticoagulant Medications, Oral | active | 2024-03 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.21 | Anticoagulant Medications, Injection | active | 2024-03 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.28 | Active Bleeding | active | 2020-11 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.29 | Fall Risk Increasing Drugs (FRIDs) | active | 2021-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.30 | Fall Risk Factors | active | 2021-02 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.32 | Total Hip Arthroplasty Surgery | active | 2021-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.33 | Total Knee Arthroplasty Surgery | active | 2021-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.46 | Opioid Medications | active | 2021-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.47 | Imaging Related to VTE | active | 2023-01 | us | hl7 | cpt |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.48 | Anticoagulant Medication | active | 2024-03 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.49 | VTE Diagnoses | active | 2025-02 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.50 | Bisphosphonate Therapy | active | 2022-02 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.51 | VTE Symptoms | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.52 | Oncology Critical Care Units | active | 2022-03 | us | hl7 | cdc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.53 | Provider Types | active | 2022-05 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.56 | FOBT_Lab | active | 2024-07 | us | hl7 | cpt |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.58 | Screening Mammogram (CPT) | active | 2024-08 | us | hl7 | cpt |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.59 | Screening Mammogram (LOINC) | active | 2024-09 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) | active | 2024-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.61 | Screening Mammogram (Grouping) | active | 2024-08 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.62 | Diagnostic Mammography (CPT) | active | 2024-08 | us | hl7 | cpt |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.63 | Diagnostic Mammography (LOINC) | active | 2024-09 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) | active | 2024-08 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.65 | Diagnostic Mammography | active | 2024-08 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.66 | Breast Cancer Biopsy and Surgical Excision | active | 2024-10 | us | hl7 | cpt |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 | active | 2024-10 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 | active | 2024-10 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.101 | Local Anesthetics | active | 2023-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.102 | Ophthalmic Epinephrines | active | 2023-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.103 | Inhaled Epinephrines | active | 2023-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.104 | Clopidogrels | active | 2023-10 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.105 | Cytochrome P450 2C19 inhibitors | active | 2023-10 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.107 | Aspirin Ingredient and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.109 | Oral Anticoagulant Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.112 | PPI and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.113 | Antiplatelet Ingredients and Risk of GI Bleeding | active | 2023-12 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds | active | 2024-07 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.117 | Clopidogrel Ingredients and Risk of GI Bleeding | active | 2024-09 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 | active | 2024-10 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.122 | Gastrointestinal bleeding episode and Risk of GI Bleeding 2 | active | 2024-09 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding | active | 2024-09 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.24 | Oxycodones | active | 2024-07 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED | active | 2020-04 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.10 | Interstitial Lung Disease ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.100 | Occupational Therapy Procedure HCPCS | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.102 | Speech Language Therapy Procedure HCPCS | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.104 | Home Health Procedure | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.106 | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.108 | Ambulance Transport Procedure | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.109 | Prefabricated Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.110 | Custom Fitted Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.111 | Custom Fabricated Spinal Orthotic Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.112 | Orthotic Device Supply | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.113 | Spinal Orthotic Device or Supply | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.116 | Spine or Neck Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.118 | Total Electric Hospital Bed Supply | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.120 | Hypoventilation Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.123 | Apnea Hypopnea Index Rate Measurement | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.124 | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.125 | Maximal Inspiratory Pressure Measurement | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.126 | Forced Vital Capacity (FVC) Measurement by Spirometry | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.127 | Oxygen Saturation Measurement At Rest | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.128 | Respiratory Assist Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.129 | Respiratory Assist Device Supply | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.13 | Cystic Fibrosis Lung Disease ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.130 | Home Oxygen Therapy Accessory | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.131 | Forced Vital Capacity (FVC) Measurement Prediction | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.132 | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.133 | Respiratory Disturbance Index | active | 2022-03 | us | hl7 | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.138 | Fracture of Bone Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.141 | Severe Obesity Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.153 | Muscle, Tendon or Joint Contracture Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.156 | Muscle Weakness or Myasthenia Gravis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.159 | Myocardial Infarction Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.162 | Amputation Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.165 | Lower Extremity Deep Vein Thrombosis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.168 | Spinal Cord Injury or Paralysis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.17 | Neoplasm of Lung or Trachea Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.171 | Demyelinating Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.174 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.177 | Wound Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.178 | Wound Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.180 | Danger to Self or Others Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.183 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.186 | Pain in Joint Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.190 | Osteoarthritis Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.197 | Turalio | active | 2022-03 | us | hl7 | rx |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.2 | Bronchiectasis Disorder ICD10CM | active | 2020-04 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.22 | Acute or Chronic Heart Failure Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.27 | Portable Liquid Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.28 | Stationary Liquid Oxygen Therapy Device | active | 2022-03 | us | hl7 | cms |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT | active | 2022-03 | us | hl7 | sct |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder | active | 2022-03 | us | hl7 | vsac |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.30 | Sleep Apnea or Breathing Related Sleep Disorder ICD10CM | active | 2022-03 | us | hl7 | icd |